Baltimore Innovation Week 2017

Aleberry, Managing Partner Gira Wieczorek is a founder at Aleberry, a design & strategy firm focused on helping startups navigate the fundraising process with deck strategy & design. She has helped clients raise over $150M in funding. Aleberry works alongside startups, advisors, venture capitalists, and accelerators for demo days, pitch sessions, and investor meetings.

Milt Reder is VP of Engineering at Yet Analytics, where he and his team use Clojure(Script) to model human experience, learning and performance. He is a co-organizer of the Baltimore Clojure meetup, now in its 4th year.

Robert Lord is the Co-Founder and President of Protenus, an analytics platform that leverages artificial intelligence to detect data breaches in healthcare. Protenus protects the nation’s top healthcare systems, ensuring trust for tens of millions of patients, and was named the 2016 International Association of Privacy Professionals’ Privacy Innovator of the Year.

Robert is a sought-after speaker and commentator in the fields of artificial intelligence, cybersecurity, healthcare analytics, and data privacy. He has been invited to speak at premier industry conferences like the HIMSS17 National Conference, to brief at the U.S. Senate, and to provide insight to national, state, and local leaders on cybersecurity preparedness. His insights have been featured in The Wall Street Journal, The Hill, Forbes, The Baltimore Sun, and a wide array of other publications.

Robert is a Fellow at the Institute for Critical Infrastructure Technology and teaches courses on entrepreneurship at Johns Hopkins. He has been named to the Baltimore Business Journal’s “Tech 10” and to Becker’s Hospital Review’s “Healthcare Entrepreneurs to Know.”

Before co-founding Protenus, Robert was an MD candidate at the Johns Hopkins University School of Medicine. Robert received his A.B. in Social Studies, magna cum laude, from Harvard University.

Dr. Miriam Boer is the founder of Sonify Biosciences, an ultrasound-based hyperthermia device company based in the Alexandria LaunchLabs incubator in New York City. Dr. Boer founded Sonify Biosciences in 2012 after receiving her PhD in biochemistry from the University of Maryland College Park, where she studied mechanosensation in bacterial cell membranes. Prior to that, Dr. Boer studied chemistry at New York University and worked as a color and flavor chemist in international research and development at PepsiCo.

Natalie D. Eddington, PhD, FAAPS, FCP, is dean of the University of Maryland School of Pharmacy (UMSOP) and a professor of pharmaceutical sciences. She is also executive director of University Regional Partnerships for the University of Maryland, Baltimore (UMB).

Dr. Eddington is a nationally known expert in drug delivery and pharmacokinetics. Her research focuses on various medications used in the treatment of cancer, epilepsy, arthritis, and drugs of abuse and on understanding the role of biopharmaceutics and pharmacokinetics in elucidating the underlying mechanisms important in optimizing drug therapy. 

Under Dr. Eddington’s leadership, the School of Pharmacy has established a number of centers and programs including the FDA-supported Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI), which is a collaborative agreement with the FDA to promote innovation in support of the development and evaluation of safe and effective products. Dr. Eddington has designed numerous international regulatory courses for clinicians and scientists from South Korea, Argentina, Brazil, the United States, and Japan on the United States’ drug development process and the FDA regulatory infrastructure surrounding medication and device development. Most recently, under Dr. Eddington’s leadership, the School has launched a transformational pharmapreneurism initiative, which seeks to position the School’s world class faculty, its wonderful students, and exceptional staff to achieve their career aspirations and address our nation’s health care, research, policy, and societal needs.

Moss Amer works at the Maryland Venture Fund, where he serves as a board observer for several portfolio companies, including Aledade, Fugue, and Harpoon Medical.

Prior to joining the Fund, Moss worked as a Senior Analyst at TCP Venture Capital, where he helped to build a 10-company portfolio with significant positive write-ups. Select investments include RedOwl Analytics (acquired by Forcepoint), WellDoc, and ZeroFOX.

Moss graduated magna cum laude from Brown University, where he studied entrepreneurship and technology management. He is a 2013 Venture for America fellow.

Gary is a Data Engineer at Arena.io. He dabbles in UI and knows way too much Clojure. He has applied FP languages (currently OCaml) and approaches to problems for over 6 years in Baltimore.

Founder, Ravi created the messaging platform that would become Sunrise Health after watching a close friend go through depression and seeing her suffer from loneliness between therapy sessions. Ravi has previous experience engineering AI products in multiple settings, from patient-doctor matching at a startup in India, to building out and selling a robotic vertical at a British multinational corporation. While a masters student at Johns Hopkins, he also helped found the VC firm A-Level Capital, raising its first fund and making multiple investments.